Edition:
United Kingdom

Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.50EUR
12:37pm BST
Change (% chg)

€-0.00 (-0.40%)
Prev Close
€0.50
Open
€0.50
Day's High
€0.50
Day's Low
€0.50
Volume
417,359
Avg. Vol
4,132,492
52-wk High
€0.60
52-wk Low
€0.40

Select another date:

Fri, May 4 2018

BRIEF-Molmed SpA Signs Master Service Agreement With Boston Children's Hospital For Supply Of Lentiviral Vectors

* SIGNS 5 YEAR MASTER SERVICE AGREEMENT WITH BOSTON CHILDREN'S HOSPITAL FOR SUPPLY OF LENTIVIRAL VECTORS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Molmed FY Net Loss Shrinks To EUR 8.5 Mln

* REPORTED ON FRIDAY FY TOTAL OPERATING REVENUES EUR 24.0 MLN VS EUR 22.8 MLN YEAR AGO

BRIEF-Molmed: Dompé Exercises Option To Start Zalmoxis In Switzerland, Turkey And Australia

* DOMPÉ EXERCISES OPTION TO ENTER MARKETS IN SWITZERLAND, TURKEY AND AUSTRALIA TO SELL ZALMOXIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Molmed: Italian Medicines Agency Sets Price Of Reimbursement For Zalmoxis

* ITALIAN MEDICINES AGENCY SETS GROSS PRICE OF REIMBURSEMENT FOR ZALMOXIS AT EUR 149,000 PER INFUSION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: